Dosing initiated in transmolecular’s phase 1/2 clinical trial for intravenous administration of 131iodine-tm601 in patients with recurrent malignant glioma

October 6th, 2008 by admin

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Tags: , , ,

Posted in Cancer |

Related posts

Comments are closed.

Recent Posts

Categories

Archives:

Search: